Corporate Profile

LabCorp (NYSE: LH), an S&P 500 company, is a leading global life sciences company that is deeply integrated in guiding patient care, providing comprehensive clinical laboratory and end-to-end drug development services. With a mission to improve health and improve lives, LabCorp delivers world-class diagnostic solutions, brings innovative medicines to patients faster and uses technology to improve the delivery of care. LabCorp reported net revenues of nearly $9.5 billion ... Read More >>

Recent News


LabCorp Announces Record 2017 Fourth Quarter and Full Year Results and Provides 2018 Guidance


LabCorp Named to FORTUNE Magazine's 2018 List of ‘World’s Most Admired Companies’


Covance Introduces Dedicated Offering Designed for Biotech, Medical Device and Diagnostics Companies

Upcoming Events

Tuesday, February 27, 2018

LabCorp Investor & Analyst Day, New York, NY

LH (Common)
Change Stock is Up 3.83
Data as of 02/16/18 4:02 p.m. ET
Refresh quote
Data provided by Nasdaq. Minimum 15 minutes delayed.
Print Page Print Page | E-mail Page E-mail Page | RSS Feeds RSS Feeds | E-mail Alerts E-mail Alerts | IR Contacts IR Contacts | Financial Tear Sheet Tear Sheet